Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
9.02
-0.38 (-4.04%)
At close: Jul 18, 2025, 4:00 PM
9.15
+0.13 (1.44%)
After-hours: Jul 18, 2025, 6:29 PM EDT
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $1.28 billion as of July 18, 2025. Its market cap has decreased by -62.85% in one year.
Market Cap
1.28B
Enterprise Value
622.28M
1-Year Change
-62.85%
Ranking
Category
Stock Price
$9.02
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $1.28B, an increase of 61.39%. That is a compound annual growth rate of 10.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 1.28B | -46.76% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.28B |
| Johnson & Johnson | 394.81B |
| AbbVie | 333.69B |
| Novo Nordisk | 292.40B |
| UnitedHealth Group | 255.84B |
| Novartis AG | 224.54B |
| Abbott Laboratories | 215.55B |
| AstraZeneca | 214.61B |